Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 4Sarcoma 3Genitourinary 3Head & Neck 2Gynecologic 2Gastrointestinal 2Endocrine 2Breast 2Thoracic 1NET 1Lymphoid 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 57Neoplasms 11Lung Neoplasms 11Small Cell Lung Carcinoma 8Thyroid Neoplasms 7Neoplasm Metastasis 6Head and Neck Neoplasms 6Carcinoma 6Breast Neoplasms 6Adenocarcinoma 6Colorectal Neoplasms 5Colonic Neoplasms 5Thyroid Diseases 4Thyroid Cancer, Papillary 4Thoracic Neoplasms 4Sarcoma 4Respiratory Tract Neoplasms 4Respiratory Tract Diseases 4Pancreatic Neoplasms 4Neuroendocrine Tumors 4Neoplasms by Site 4Melanoma 4Lung Diseases 4Endometrial Neoplasms 4Endocrine System Diseases 4Endocrine Gland Neoplasms 4Carcinoma, Renal Cell 4Carcinoma, Bronchogenic 4Bronchial Neoplasms 4Uterine Cervical Neoplasms 3

Interventions

entrectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has announcements × Brain Neoplasms × Thoracic × Clear all
NCT02568267 2026-05-27

STARTRK-2

Hoffmann-La Roche

Phase 2 Active not recruiting
534 enrolled 1 FDA
BreastCNSDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidNETSarcomaThoracic

Thyroid Cancer, Papillary, Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Colorectal Neoplasms, Lymphoma, Large-Cell, Anaplastic, Cholangiocarcinoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡